{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:28:32Z","timestamp":1778797712634,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pmr.2026.01.012","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:26:29Z","timestamp":1771331189000},"page":"187-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disparities in Spasticity Access and Care"],"prefix":"10.1016","volume":"37","author":[{"given":"Monica","family":"Verduzco-Gutierrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb T.","family":"Cable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha L.","family":"Romanoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2026.01.012_bib1","series-title":"Physical medicine and rehabilitation","first-page":"487","article-title":"Spasticity","author":"Francisco","year":"2016"},{"issue":"8","key":"10.1016\/j.pmr.2026.01.012_bib2","first-page":"864","article-title":"AAPM&R consensus guidance on spasticity assessment and management","volume":"16","author":"Verduzco-Gutierrez","year":"2024","journal-title":"Pharm Manag PM R"},{"issue":"8","key":"10.1016\/j.pmr.2026.01.012_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002099","article-title":"Racial\/ethnic and sex differences in emergency medical services transport among hospitalized US stroke patients: analysis of the national get with the guidelines-stroke registry","volume":"4","author":"Mochari-Greenberger","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.pmr.2026.01.012_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/STROKEAHA.121.036263","article-title":"Evidence-based disparities in stroke care metrics and outcomes in the United States: a systematic review","volume":"53","author":"Ikeme","year":"2022","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.pmr.2026.01.012_bib5","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/STR.0000000000000173","article-title":"Recommendations for the establishment of stroke systems of care: a 2019 update","volume":"50","author":"Adeoye","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.pmr.2026.01.012_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.616097","article-title":"Prevalence and risk factors for spasticity after stroke: a systematic review and meta-analysis","volume":"11","author":"Zeng","year":"2021","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.pmr.2026.01.012_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/PHM.0000000000001823","article-title":"Prevalence and treatment characteristics of spastic hypertonia on first-time admission to acute inpatient rehabilitation","volume":"101","author":"Dragojlovic","year":"2022","journal-title":"Am J Phys Med Rehabil"},{"issue":"15","key":"10.1016\/j.pmr.2026.01.012_bib8","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1080\/09638288.2018.1555620","article-title":"Prevalence of upper-limb spasticity and its impact on care among nursing home residents with prior stroke","volume":"42","author":"Shiner","year":"2020","journal-title":"Disabil Rehabil"},{"issue":"8","key":"10.1016\/j.pmr.2026.01.012_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jamda.2020.01.005","article-title":"Prevalence of spasticity in nursing home residents","volume":"21","author":"Gill","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.pmr.2026.01.012_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.apmr.2016.09.124","article-title":"Prevalence and effect of problematic spasticity after traumatic spinal cord injury","volume":"98","author":"Holtz","year":"2017","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"10.1016\/j.pmr.2026.01.012_bib11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0003-9993(03)00368-X","article-title":"Spasticity in adults living in a developmental center","volume":"84","author":"Pfister","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"issue":"9650","key":"10.1016\/j.pmr.2026.01.012_bib12","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0140-6736(08)61690-6","article-title":"Closing the gap in a generation: health equity through action on the social determinants of health","volume":"372","author":"Marmot","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pmr.2026.01.012_bib13","article-title":"Physicians protest harmful anthem emergency care coverage policy","author":"Robeznieks","year":"2017","journal-title":"AMA Wire"},{"issue":"7","key":"10.1016\/j.pmr.2026.01.012_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.21010","article-title":"Provision of stroke care services by community disadvantage status in the US, 2009-2022","volume":"7","author":"Hsia","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.pmr.2026.01.012_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.62271","article-title":"Hospital patient demographics and administration of intravenous thrombolysis in acute ischemic stroke","volume":"8","author":"Kabangu","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.pmr.2026.01.012_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.apmr.2024.10.010","article-title":"Disparities in access to, use of, and quality of rehabilitation after stroke in the United States: a scoping review","volume":"106","author":"Freburger","year":"2025","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2026.01.012_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PHM.0000000000002297","article-title":"Upper limb spasticity: the quality of online patient resources","volume":"103","author":"Larkin","year":"2024","journal-title":"Am J Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.pmr.2026.01.012_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/09638288.2020.1767219","article-title":"Walking the talk: understanding how language barriers affect the delivery of rehabilitation services","volume":"44","author":"Mirza","year":"2022","journal-title":"Disabil Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2026.01.012_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/geriatrics6010021","article-title":"Long-term care resident awareness and interest in spasticity treatments","volume":"6","author":"Hacker","year":"2021","journal-title":"Geriatrics"},{"issue":"3","key":"10.1016\/j.pmr.2026.01.012_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PHM.0000000000002375","article-title":"Disparities in access to spasticity chemodenervation specialists in the United States: a retrospective cross-sectional study","volume":"103","author":"Kazerooni","year":"2024","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.pmr.2026.01.012_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.apmr.2022.11.008","article-title":"A comparison of acute ischemic stroke patients discharged to inpatient rehabilitation vs a skilled nursing facility: the Paul coverdell National Acute Stroke Program","volume":"104","author":"Pattath","year":"2023","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2026.01.012_bib23","doi-asserted-by":"crossref","first-page":"jrm11626","DOI":"10.2340\/jrm.v55.11626","article-title":"Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina","volume":"55","author":"Esquenazi","year":"2023","journal-title":"J Rehabil Med"},{"issue":"9","key":"10.1016\/j.pmr.2026.01.012_bib26","first-page":"1116","article-title":"A consensus statement on the use of botulinum toxin in pediatric patients","volume":"14","author":"Vova","year":"2022","journal-title":"Pharm Manag PM R"},{"issue":"S1","key":"10.1016\/j.pmr.2026.01.012_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032363","article-title":"Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): development, insights, and impact","volume":"102","author":"Gormley","year":"2023","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.pmr.2026.01.012_bib28","first-page":"246","article-title":"Phenol neurolysis for management of focal spasticity in the distal upper extremity","volume":"12","author":"Karri","year":"2020","journal-title":"Pharm Manag PM R"},{"issue":"3","key":"10.1016\/j.pmr.2026.01.012_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/PHM.0000000000001563","article-title":"The time course of onset and peak effects of phenol neurolysis","volume":"100","author":"Zhang","year":"2021","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.pmr.2026.01.012_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007517","article-title":"The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database","volume":"5","author":"Narendran","year":"2015","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.pmr.2026.01.012_bib31","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3390\/jcm13071840","article-title":"Evaluating community-based intrathecal baclofen therapy: effectiveness, safety, and feasibility","volume":"13","author":"van der Gaag","year":"2024","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.pmr.2026.01.012_bib32","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/ner.13038","article-title":"Efficiency and safety of aftercare with intrathecal baclofen on location","volume":"22","author":"Goslinga-van der Gaag","year":"2019","journal-title":"Neuromodulation"},{"issue":"10","key":"10.1016\/j.pmr.2026.01.012_bib33","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.3390\/jcm14103579","article-title":"Socioeconomic disadvantage, residential remoteness and access to specialised interventions in cerebral palsy: a cross-sectional study","volume":"14","author":"Paget","year":"2025","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.pmr.2026.01.012_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0269215520963855","article-title":"Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial","volume":"35","author":"Lindsay","year":"2021","journal-title":"Clin Rehabil"},{"issue":"3","key":"10.1016\/j.pmr.2026.01.012_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/02692155221133522","article-title":"Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: secondary analysis of a randomised controlled trial","volume":"37","author":"Lindsay","year":"2023","journal-title":"Clin Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2026.01.012_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40120-024-00692-9","article-title":"Treatment patterns and healthcare costs among patients with stroke and spasticity: a 2-Year longitudinal study","volume":"14","author":"Hull","year":"2025","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1016\/j.pmr.2026.01.012_bib37","doi-asserted-by":"crossref","DOI":"10.2340\/16501977-2753","article-title":"A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: an international group consensus","volume":"53","author":"Francisco","year":"2021","journal-title":"J Rehabil Med"},{"issue":"12","key":"10.1016\/j.pmr.2026.01.012_bib43","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/PHM.0000000000001594","article-title":"Spasticity outpatient evaluation via telemedicine: a practical framework","volume":"99","author":"Verduzco-Gutierrez","year":"2020","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.pmr.2026.01.012_bib44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.23736\/S1973-9087.17.04808-0","article-title":"A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework","volume":"54","author":"Turner-Stokes","year":"2018","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.pmr.2026.01.012_bib45","doi-asserted-by":"crossref","DOI":"10.2340\/jrm.v55.6498","article-title":"Goal attainment scaling in rehabilitation: an educational review providing a comprehensive didactical tool box for implementing goal attainment scaling","volume":"55","author":"Bard-Pondarr\u00e9","year":"2023","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.pmr.2026.01.012_bib48","unstructured":"Botulinum Toxin Injections, proposed Local Coverage Determination. Centers for Medicare and Medicaid Services. Posted May 30, 2024. Accessed June 29, 2025. Available at: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx?lcdid=39856&ver=3&keyword=botulinumtoxin&keywordType=starts&areaId=all&docType=NCA,CAL,NCD,MEDCAC,TA,MCD,6,3,5,1,F,P&contractOption=all&sortBy=relevance&bc=1."}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965126000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965126000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:54:50Z","timestamp":1778795690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965126000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1047965126000124"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2026.01.012","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in Spasticity Access and Care","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2026.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}